Sign in New Account

The Summit

12th - 14th October 2010

Next Generation Pharma Manufacturing Summit 2010

Summit Venue
Hotels Van Oranje, The Netherlands

The Next Generation Pharmaceutical Summit October 2010 will once again serve as an arena for senior level executives to engage in clear and focused dialogue with their peers and examine their management objectives in a relaxed and vibrant environment.

  • Previous Summits

White Papers

Vocollect: Sustaining a Successful Voice Deployment

Yesterday’s tired approaches are simply inadequate for today’s world where supply chain organizations are struggling mightily to squeeze as much profit and performance out of their operations as possible. These overwhelming expectations create many challenges – and opportunities – for DC/warehouse leaders. Their ability to inspire and enable their workforces to achieve peak performance gets tested on an hourly basis.

Discovering and developing new drugs is a high risk, high cost and only occasionally high reward enterprise. Industry data suggests that for every 10,000 new molecular entities prepared only 1 will make it to market and the process from concept to market often takes in excess of 10 years. Moreover, very few marketed drugs ever recoup the significant R&D investment required to bring them to patients, which today can exceed $800 million.

Product Lifecycle Management: Maximizing profit and leveraging innovation

The cost of developing a new drug is continuously rising. Many other factors, such as stricter regulations and stronger global competition, are also creating major challenges. If a pharmaceutical company intends to increase its market share and return on investment, it must consider how to maintain a drug‘s profitability even after its patents have expired. Product Lifecycle Management (PLM) is a viable option for extending profitability, and there are several methods for approaching PLM effectively. What is crucial, however, is to plan for it early on, even, if possible, before the drug actually enters the market.

Vetter Pharma: Five keys to reducing time-to-market

With development times measured in years, increasing costs represent a major challenge confronting pharmaceutical and biotechnology companies. As a result, reducing time-to-market is an essential component in any business strategy, particularly when the end of patent protection is considered. One solution is to partner with a contract manufacturer that provides intelligent concepts and the proper experience, not only with respect to the production itself, but also with regulatory authorities. Planning early on is crucial to speeding up the time-to-market process.

Finding a suitable contract manufacturer is, perhaps, one of the most viable options. The pharmaceutical company can concentrate effort and money on research and development and marketing, while the contract manufacturer takes care of the manufacturing process, including validation, support for license application and packaging. In addition, outsourcing can be scheduled into the strategic planning of a drug’s lifecycle. During the early development phases, which last years, a partner with the necessary facilities and experience can be sought out and brought onboard. Finding the proper partner requires careful screening, hence a certain amount of time. A number of criteria should be met. The first is simply know-how and experience: How long has a contract manufacturer been in the business and what kind of work has the company done, i.e. with what kind of drugs. The more experience, the smoother the collaboration. Finally, to ensure effective workings, outsourcing has to be made an integral aspect of project management.

INUMAC

Laboratoria Smeets specializes in pharmaceutical powders. When the intake of larger quantities is required, the usage of powders offers benefits such as faster absorption and less problematic intake. In some niches powders remain very popular and as a result, the market continues to grow. We have developed for the benefit of our distribution partners a series of innovative products dedicated to those niches.